Nomura Holdings’s Ambrx Biopharma Inc AMAM Stock Holding History

Nomura Holdings’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-57,268	Closed	-$511K	–	1708
2023 Q1	$511K	Buy	+57,268	New	+$288K	﹤0.01%	1132

Other funds holding AMAM

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Nomura Holdings's AMAM Position: Q2 2023 in Review

Nomura Holdings sold out of Ambrx Biopharma Inc (AMAM) in Q2 2023, closing a stake of 57,268 shares — an estimated $511K sold.

Nomura Holdings first reported a position in AMAM in Q1 2023 and held it in 1 quarter. The position peaked at $511K in Q1 2023. 42 funds tracked by Wall St. Rank hold AMAM as of Q2 2023.

Nomura Holdings reported no remaining Ambrx Biopharma Inc position as of Q2 2023 after selling out during the quarter.
Nomura Holdings sold 57,268 Ambrx Biopharma Inc shares in Q2 2023, an estimated $511K.
Nomura Holdings first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 1 quarter.
Nomura Holdings's Ambrx Biopharma Inc position peaked at $511K in Q1 2023.
42 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q2 2023.

Based on Nomura Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.